Adaptive Biotechnologies Corp Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for April 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 140,220 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 140,220 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 148,010 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 7,790 | 49,233 | 148,010 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,685 | 73,849 | 155,800 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,685 | 73,849 | 155,800 | |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.59 | 3,510 | 153,001 | 69,360 | 72.9 K to 69.4 K (-4.82 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 43.59 | 3,510 | 153,001 | 69,360 | 72.9 K to 69.4 K (-4.82 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.85 | 4,280 | 183,398 | 72,870 | 77.2 K to 72.9 K (-5.55 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 42.85 | 4,280 | 183,398 | 72,870 | 77.2 K to 72.9 K (-5.55 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.79 | 5,200 | 217,308 | 69,360 | 74.6 K to 69.4 K (-6.97 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.79 | 5,200 | 217,308 | 69,360 | 74.6 K to 69.4 K (-6.97 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.17 | 2,090 | 86,045 | 74,560 | 76.7 K to 74.6 K (-2.73 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.17 | 2,090 | 86,045 | 74,560 | 76.7 K to 74.6 K (-2.73 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.85 | 500 | 19,925 | 76,650 | 77.2 K to 76.7 K (-0.65 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.85 | 500 | 19,925 | 76,650 | 77.2 K to 76.7 K (-0.65 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 7,790 | 49,233 | 77,150 | 69.4 K to 77.2 K (+11.23 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.35 | 3,000 | 124,050 | 69,360 | 72.4 K to 69.4 K (-4.15 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 41.35 | 3,000 | 124,050 | 69,360 | 72.4 K to 69.4 K (-4.15 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.24 | 8,685 | 349,484 | 72,360 | 81 K to 72.4 K (-10.72 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.24 | 8,685 | 349,484 | 72,360 | 81 K to 72.4 K (-10.72 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,685 | 73,849 | 81,045 | 69.4 K to 81 K (+16.85 %) |
| Apr 22 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,685 | 73,849 | 81,045 | 69.4 K to 81 K (+16.85 %) |
| Apr 21 2021 | ADPT | Adaptive Biotechno ... | Palaniappan Jyoti | SVP, Diagnostics, T ... | Option Exercise | M | 22.55 | 1,301 | 29,338 | 107,647 | |
| Apr 21 2021 | ADPT | Adaptive Biotechno ... | Palaniappan Jyoti | SVP, Diagnostics, T ... | Sell | S | 41.25 | 1,301 | 53,666 | 9,158 | 10.5 K to 9.2 K (-12.44 %) |
| Apr 21 2021 | ADPT | Adaptive Biotechno ... | Palaniappan Jyoti | SVP, Diagnostics, T ... | Buy | M | 22.55 | 1,301 | 29,338 | 10,459 | 9.2 K to 10.5 K (+14.21 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 153,000 | |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 43.04 | 2,000 | 86,080 | 20,604 | 22.6 K to 20.6 K (-8.85 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 22,604 | 20.6 K to 22.6 K (+9.71 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 339,250 | |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 44.50 | 2,000 | 89,000 | 22,894 | 24.9 K to 22.9 K (-8.03 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 2,000 | 15,600 | 24,894 | 22.9 K to 24.9 K (+8.74 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 4,500 | 35,100 | 78,500 | |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 43.41 | 4,500 | 195,345 | 1,504 | 6 K to 1.5 K (-74.95 %) |
| Apr 16 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 4,500 | 35,100 | 6,004 | 1.5 K to 6 K (+299.20 %) |
| Apr 09 2021 | ADPT | Adaptive Biotechno ... | ADAMS R MARK | Chief Operating Off ... | Sell | S | 42.34 | 3,586 | 151,831 | 67,018 | 70.6 K to 67 K (-5.08 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 25,000 | |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 10,000 | 63,200 | 35,000 | |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 42.34 | 806 | 34,126 | 21,604 | 22.4 K to 21.6 K (-3.60 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 41.59 | 9,194 | 382,378 | 22,410 | 31.6 K to 22.4 K (-29.09 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 40.95 | 10,000 | 409,500 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 10,000 | 63,200 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.78 | 100 | 4,378 | 1,748,461 | 1.7 M to 1.7 M (-0.01 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.00 | 1,957 | 84,151 | 1,748,561 | 1.8 M to 1.7 M (-0.11 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.04 | 2,943 | 123,724 | 1,750,518 | 1.8 M to 1.8 M (-0.17 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.45 | 1,100 | 45,595 | 1,753,461 | 1.8 M to 1.8 M (-0.06 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 40.61 | 3,900 | 158,379 | 1,754,561 | 1.8 M to 1.8 M (-0.22 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 43.08 | 1,200 | 51,696 | 1,758,461 | 1.8 M to 1.8 M (-0.07 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 42.48 | 2,200 | 93,456 | 1,759,661 | 1.8 M to 1.8 M (-0.12 %) |
| Apr 08 2021 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 41.08 | 1,600 | 65,728 | 1,761,861 | 1.8 M to 1.8 M (-0.09 %) |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 31.71 | 1,354 | 42,935 | 47,396 | |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 21,250 | |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,042 | 8,128 | 26,042 | |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 40.00 | 4,167 | 166,680 | 15,036 | 19.2 K to 15 K (-21.70 %) |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 31.71 | 1,354 | 42,935 | 19,203 | 17.8 K to 19.2 K (+7.59 %) |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 17,849 | 16.1 K to 17.8 K (+11.02 %) |
| Apr 02 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,042 | 8,128 | 16,078 | 15 K to 16.1 K (+6.93 %) |